These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gsα Regulates Macrophage Foam Cell Formation During Atherosclerosis. Ma C; Li Y; Tian M; Deng Q; Qin X; Lu H; Gao J; Chen M; Weinstein LS; Zhang M; Bu P; Yang J; Zhang Y; Zhang C; Zhang W Circ Res; 2024 Mar; 134(7):e34-e51. PubMed ID: 38375634 [TBL] [Abstract][Full Text] [Related]
7. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Wolfs IM; Donners MM; de Winther MP Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328 [TBL] [Abstract][Full Text] [Related]
8. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb. Liu X; Wu J; Tian R; Su S; Deng S; Meng X Biomed Pharmacother; 2020 Sep; 129():110433. PubMed ID: 32768936 [TBL] [Abstract][Full Text] [Related]
9. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques. Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411 [TBL] [Abstract][Full Text] [Related]
10. Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation. Zhao JF; Shyue SK; Kou YR; Lu TM; Lee TS Int J Biol Sci; 2016; 12(7):812-23. PubMed ID: 27313495 [TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice. Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724 [TBL] [Abstract][Full Text] [Related]
12. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy. Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930 [TBL] [Abstract][Full Text] [Related]
13. Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation. Li H; Cao Z; Wang L; Liu C; Lin H; Tang Y; Yao P Front Immunol; 2022; 13():843712. PubMed ID: 35432323 [TBL] [Abstract][Full Text] [Related]
14. Naringin Inhibits Macrophage Foam Cell Formation by Regulating Lipid Homeostasis and Metabolic Phenotype. Liu Y; Tang X; Yuan H; Gao R Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732567 [TBL] [Abstract][Full Text] [Related]
15. Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease. Maguire EM; Pearce SWA; Xiao Q Vascul Pharmacol; 2019 Jan; 112():54-71. PubMed ID: 30115528 [TBL] [Abstract][Full Text] [Related]
16. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation. Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021 [TBL] [Abstract][Full Text] [Related]
17. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis. Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825 [TBL] [Abstract][Full Text] [Related]
18. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345 [No Abstract] [Full Text] [Related]